Castleview Partners’s Milestone Scientific MLSS Stock Holding History
Bought
Maintained
Sold
Other funds holding MLSS
BCM
SFA
Castleview Partners's MLSS Position: Q2 2023 in Review
Castleview Partners sold out of Milestone Scientific (MLSS) in Q2 2023, closing a stake of 11,750 shares — an estimated $10.6K sold.
Castleview Partners first reported a position in MLSS in Q4 2021 and held it in 6 quarters. The position peaked at $150K in Q2 2022. 32 funds tracked by Wall St. Rank hold MLSS as of Q2 2023.
- Castleview Partners reported no remaining Milestone Scientific position as of Q2 2023 after selling out during the quarter.
- Castleview Partners sold 11,750 Milestone Scientific shares in Q2 2023, an estimated $10.6K.
- Castleview Partners first reported a position in Milestone Scientific in Q4 2021 and held it in 6 quarters.
- Castleview Partners's Milestone Scientific position peaked at $150K in Q2 2022.
- 32 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2023.
Based on Castleview Partners's 13F filing for Q2 2023, filed 15 Aug 2023.